USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
HELIX THERAPEUTICS, LLC
Address:
HELIX THERAPEUTICS, LLC
25 Science Park
New Haven, CT 06511
Phone:
N/A
URL:
N/A
EIN:
120582314
DUNS:
788852437
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $328,489.00 2

Award List:

Targeted CCR5 Gene Inactivation Using Peptide Nucleic Acids

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$99,999.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The proposed work is to develop a therapeutic gene targeting agent for the treatment of HIV disease. Our approach is to use triplex-forming oligonucleotides (TFOs) and peptide nucleic acids (PNAs), which bind to duplex DNA in a sequence-specific manner. Initial… More

Beta-Globin Gene Correction Using Peptide Nucleic Acids for the Treatment of Sick

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$228,490.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This is a proposal to test the feasibility of using triplex-forming oligonucleotides to correct the sickle cell disease (SCD) mutation in human CD34+ cells. SCD is one of the most common human genetic diseases and is th e result of one specific inherited mutation… More